Over 50% of U.S. News & World Report's "Best Heart Hospitals" Are Certified to Implant the SynCardia Total Artificial Heart
SynCardia Systems, Inc. (www.syncardia.com), manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that over half of the top 50 centers honored in U.S. News & World Report's "Best Hospitals" list for cardiology and heart surgery for 2013-2014, offer the SynCardia temporary Total Artificial Heart.
"The fact that these top U.S. transplant centers offer the SynCardia Total Artificial Heart demonstrates its growing acceptance as the new standard of care for end-stage biventricular heart failure," said Michael Garippa, SynCardia CEO and President.
In June, U.S. News and World Report published its annual list of "Best Children's Hospitals" for cardiology and heart surgery. Among the top 10 were seven pediatric centers that offer the SynCardia Total Artificial Heart: #2 Children's Hospital of Philadelphia (CHOP), #3 Texas Children's Hospital, #5 Cincinnati Children's Hospital Medical Center, #11 Children's Hospital of Wisconsin, #26 Mattel Children's Hospital UCLA, #32 Shands Hospital for Children at the University of Florida and #34 Phoenix Children's Hospital.
As of July 18, SynCardia Certified Centers worldwide have performed a record-breaking 100 implants of the SynCardia Total Artificial Heart in 2013. This milestone was achieved three months earlier than in 2012, when the 100th implant was performed on Oct. 16. Worldwide, there have been more than 1,200 implants of the Total Artificial Heart, accounting for more than 315 patient years of life.
There are currently 87 SynCardia Certified Centers worldwide, including 48 in the U.S. An additional 33 centers are currently completing SynCardia's four-phase certification program.
For up-to-date information, please visit: http://www.syncardia.com